Seroprevalence of anti-hepatitis a antibody among 1 - 15 year old children in Kashan-Iran

Hepatitis Monthly

Volumn 13, Issue 5, 2013, Pages

  Ardakani, Abbas Taghavi ^a   Soltani, Babak ^a   Sehat, Mojtaba ^a   Namjoo, Somayeh ^a   Rezaei, Mostafa Haji ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibody; Epidemiology; Hepatitis a

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; SEROPREVALENCE;

EID: 84881231632     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.10553     Document Type: Article

References (35)

1. Rosenthal P. Hepatitis A: a preventable threat. J Pediatr Gastroen-terol Nutr. 2002;35(5):595-6.
2. Davidson LJ, George LE, Kalevitch MV, Rudd DP. Calming the pan-ic over hepatitis A. Nursing. 2004;34(6):45-7.
3. Su CW, Wu JC, Huang YS, Huo TI, Huang YH, Lin CC, et al. Com-parison of clinical manifestations and epidemiology between acute hepatitis A and acute hepatitis E in Taiwan.J Gastroenterol Hepatol. 2002;17(11):1187-91.
4. Duval B, De Serres G, Ochnio J, Scheifele D, Gilca V. Nationwide ca-nadian study of hepatitis a antibody prevalence among children eight to thirteen years old. Pediatr Infect Dis J. 2005;24(6):514-9.
5. Charles LT. Hepatitis A in the United States. Pediatr Infec Dis J. 2004;23(6):551-2.
6. Nada Y, William F. Viral hepatitis. Kliegman Nelson Textbook of Pediatrics.Philadelphia: Sunders Elsevier; 2011. p. 1393-1397.
7. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus su-perinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338(5):286-90.
8. Nordenfelt E, Atack W, Al-Kandani S, Al-Nakib W. Hepatitis A in Kuwait. J Kuwait Med Assoc. 1985;19:103-108.
9. Tapia-Conyer R, Santos JI, Cavalcanti AM, Urdaneta E, Rivera L, Manterola A, et al. Hepatitis A in Latin America: a changing epi-demiologic pattern. Am J Trop Med Hyg. 1999;61(5):825-9.
10. Pinho JR, Sumita LM, Moreira RC, de Souza VA, Saraceni CP, Oba IT et al. Duality of patterns in hepatitis A epidemiology: a study involving two socioeconomically distinct populations in Campinas, Sao Paulo State, Brazil. Rev Inst Med Trop Sao Paulo. 1998;40(2):105-6.
11. Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through ac-tive or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-7):1-23.
12. Prevention of hepatitis A infections: guidelines for use of hepa-titis A vaccine and immune globulin. American Academy of Pe-diatrics Committee on Infectious Diseases. Pediatrics. 1996;98(6 Pt 1):1207-15.
13. Sung JJ. Epidemiology of hepatitis A in Asia and experience with the HAV vaccine in Hong Kong. J Viral Hepat. 2000;7 Suppl 1:27-8.
14. Director of Meteorology Bureau of Kashan. 2012; Available from:
15. Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specific seroprevalence of hepatitis A infection among chil-dren visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol. 2004;19(3):275-8.
16. Feinstone SM, Kapikian AZ, Purceli RH. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science. 1973;182(4116):1026-8.
17. Lemon SM. Type A viral hepatitis. New developments in an old disease. N Engl J Med. 1985;313(17):1059-67.
18. Cohen JI, Feinstone S, Purcell RH. Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs. J Infect Dis. 1989;160(5):887-90.
19. Costa-Mattioli M, Monpoeho S, Nicand E, Aleman MH, Billaudel S, Ferre V. Quantification and duration of viraemia during hepa-titis A infection as determined by real-time RT-PCR. J Viral Hepat. 2002;9(2):101-6.
20. Kemmer NM, Miskovsky EP. Hepatitis A. Infect Dis Clin North Am. 2000;14(3):605-15.
21. Hadler SC, Hollinger FB, Lemon SM, Margolis HS. Global impact of hepatitis virus infection changing patterns. In: Hadler SC, Hollinger FB, Lemon SM, Margolis HS, editors.Viral hepatitis and liver disease.Baltimore: Williams and Wilkins; 1991. p. 14-20.
22. McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med. 1996;150(7):733-9.
23. Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzade-gan Z, et al. HAV in Isfahan province: a population-based study. Trop Gastroenterol. 2008;29(3):160-2.
24. Kazemi Seyed Alinaghi, Mahram Manoochehr, Koosha Ali, Amir-moghaddami Hamid Reza. Seroprevalence of Hepatitis A in 7-10 year-old children. Iran J Ped. 2007;17(1).
25. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Sero-prevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011;11(4):285-8.
26. Moschen ME, Floreani A, Zamparo E, Baldo V, Majori S, Gasparini V, et al. Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy. Eur J Epidemiol. 1997;13(8):875-8.
27. Alkhalidi J, Alenezi B, Al-Mufti S, Hussain E, Askar H, Kemmer N, et al. Seroepidemiology of hepatitis A virus in Kuwait. World J Gas-troenterol. 2009;15(1):102-5.
28. Wang SM, Liu CC, Huang YS, Yang YJ, Lei HY. Change in hepati-tis A virus seroepidemiology in southern Taiwan: a large per-centage of the population lack protective antibody. J Med Virol. 2001;64(2):104-8.
29. Das K, Jain A, Gupta S, Kapoor S, Gupta RK, Chakravorty A, et al. The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the Euro-pean countries. Eur J Epidemiol. 2000;16(6):507-10.
30. Barzaga BN. Hepatitis A shifting epidemiology in South-East Asia and China. Vaccine. 2000;18 Suppl 1:S61-4.
31. Salehi M, Sanei M. Hepatitis A seroepidemiology in under 30 years old population. J Guilan M Sci. 2005;10:37-38.
32. de Alencar Ximenes RA, Martelli CM, Merchan-Hamann E, Mon-tarroyos UR, Braga MC, de Lima ML et al. Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-west regions of Brazil. Int J Epidemiol. 2008;37(4):852-61.
33. Werzberger A, Mensch B, Nalin DR, Kuter BJ. Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTA. Vaccine. 2002;20(13-14):1699-701.
34. Wiedermann G, Kundi M, Ambrosch F, Safary A, D'Hondt E, Delem A. Inactivated hepatitis A vaccine: long-term antibody persistence. Vaccine. 1997;15(6-7):612-5.
35. Averhoff F, Shapiro CN, Bell BP, Hyams I, Burd L, Deladisma A, et al. Control of hepatitis A through routine vaccination of chil-dren. JAMA. 2001;286(23):2968-73.